Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients - European Medical Journal

Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

Download PDF
Iciar Martín-Timón, Cristina Sevillano-Collantes, Juan José Marín-Peñalver, *Francisco Javier del Cañizo-Gómez

The authors have declared no conflicts of interest.

EMJ. ;1[4]:89-97. DOI/10.33590/emj/10313882.
Type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), cardiovascular risk factors, dyslipidaemia, hypertension, obesity, microalbuminuria, homocysteine, subclinical cardiovascular disease

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


People with Type 2 diabetes mellitus (T2DM), compared with non-diabetic individuals, have increased cardiovascular risk. Part of this excess risk is associated with a higher prevalence of other cardiovascular risk factors in these patients, such as obesity, dyslipidaemia, and hypertension. However, the increased cardiovascular risk present in T2DM cannot be attributed entirely to the high prevalence of traditional risk factors and other non-traditional risk factors may also be important for people with T2DM. Evidence suggests that in patients with T2DM, treatment of cardiovascular risk factors is very important in reducing the risk of cardiovascular disease (CVD). The poor control of risk factors observed in the diabetic population supports the need for more aggressive treatment of modifiable cardiovascular risk factors, especially in patients with previous CVD. There is little evidence on the independent association between traditional and non-traditional cardiovascular risk factors, however these risk factors do not appear in isolation and are produced at the same time, exacerbating the risk of a cardiovascular event. Targeting multiple markers of CVD risk offers the best chance of improving CVD outcomes. The objective of this review is to highlight the importance of managing cardiovascular risk factors in patients with T2DM.

Please view the full content in the pdf above.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally